Latest rheumatoid arthritis Stories
Physicians Indicate that Switching of Currently Treated Patients to Biosimilar Infliximab Is Likely to be Limited, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
Medac Pharma Brings Rasuvo From U.S. Concept to Launch in One Year CHICAGO, Oct.
-- Polyarticular juvenile idiopathic arthritis (JIA) occurs in approximately 25 percent of all JIA patients NORTH CHICAGO, Ill., Oct.
Non-profit arthritis support group CreakyJoints addresses underserved housekeeping needs of those with arthritis and rheumatic disease with new “Clean My House” monthly member drawing.
Featured Presentations Highlight Data From Approved and Investigational Agents Across Amgen's Dermatology Portfolio THOUSAND OAKS, Calif., Oct.
Be Joint Smart to educate roughly 35,000 local residents with PsA about their disease PORTLAND, Ore., Sept.
Be Joint Smart to educate roughly 150,000 local residents with PsA about their disease PORTLAND, Ore., Sept.
Arthritis Society says patient safety paramount as new class of medications become available Toronto, ON (PRWEB) September 18, 2014 With the arrival
-Enhances Capabilities for the Precision Medicine in Immuno-oncology and Autoimmune Disease Areas- LOS ANGELES and LEIPZIG, Germany, Sept. 17, 2014 /PRNewswire/ -- ImaginAb, Inc.
Rheumatologists Report that the Vast Majority of RA Patients Who are Candidates for Biologic Treatment Receive a Biologic, According to Findings from Decision Resources Group BURLINGTON, Mass.,
- Withering but not falling off, as a blossom that persists on a twig after flowering.